Acepodia is a clinical-stage biotechnology company developing accessible cancer cell therapies using its Antibody-Cell Conjugation (ACC) technology. By linking tumor-targeting antibodies to immune effector cells like gamma delta T cells and NK cells, Acepodia’s ACE therapies offer enhanced tumor targeting, with potential to treat a broad range of solid tumors and hematologic cancers.
Acepodia Highlights:
Overview
- Website: acepodia.com
- Headquarters: Alameda, California
- Employees: 57
- Founded: 2016
- Email: info@acepodiabio.com
- Revenue: $8.8M
- Valuation: n/a
Contacts
- Email: ***@acepodia.com
Similar companies
Frequently Asked Questions related to Acepodia
Acepodia is located in .
Yes, Acepodia is a Silicon Valley company.
Acepodia total funding is .
Acepodia revenue is .
Acepodia’s number of employees is .
Acepodia’s CEO name is .
Acepodia was founded in .
Acepodia’s contact email is .
